PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

40,991 stories, page 416 of 684

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech CEO Ying Huang steps down, Alan Bash named interim

Investing.com CanadaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) CEO Ying Huang exits as board appoints interim chief

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Announces CEO Transition

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech CEO Ying Huang Steps Down; Search Begins

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Puerto Rico imports $3.254 billion in generic drugs and faces the threat of tariffs of up to 200%

WJournalprOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TrialBlazer vs. Australia_ Why U.S. Biotech Regulation is Slow(1)

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Co. $TAK Shares Purchased by Renaissance Technologies LLC

MarketBeatOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Working for UKHSA

Learn about the UK Health Security Agency, including who we are, what we do, available opportunities...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Renaissance Technologies LLC Has $52.55 Million Stock Position in West Pharmaceutical Services, Inc. $WST

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RFK Jr.’s Big Promise to Ban Pharmaceutical Ads Is in the Slow Lane

News of the United States - NOTUSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharma packaging under PPWR: Safety and validation demands challenge compliance

Packaging InsightsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From a small-town pledge to the big time: A quest to turn central Ohio into a biotech hub

CNNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sei Investments Co. Has $35.62 Million Position in Teva Pharmaceutical Industries Ltd. $TEVA

MarketBeatOriginal source
🌍Medianovartis.comTier 3 · Secondary coverage

Small shifts. Big impact. The leadership choices that matter most in the age of AI

NovartisOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[Click e-Stock] "Samsung Epis Holdings: Focus on New Drug Development Strategy Over Short-Term Earnings... Target Price Lowered"

아시아경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Benefiting from Chinese pharma innovation

The Express TribuneOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

DHSC: workforce management information June 2026

Reports on departmental staff numbers and costs.

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Compounded GLP-1 drugs creating concern among doctors and FDA

Fox 59Original source
🌍discoverynews.google.comTier 3 · Aggregated media

The Intelligent Laboratory: How AI, Automation & Digital Science Are Transforming Pharmaceutical Quality

Microbioz IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zentalis' Azenosertib: A Calculated Wager on a Dual-Track Path to Ovarian Cancer Approval

Kavout | AIOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea selects manager for ₩170 bil. phase 3 fund, moves closer to ₩1 tri. bio megafund

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca achieves revenues of 15.4 billion dollars supported by the growth in pharmaceutical sales

المتداول العربيOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

North-West University: Training future experts in pharmaceutical sciences

Study InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Aribio and ForeverNK join to develop next-gen Alzheimer’s drugs in South Korea - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The next generation of pharmaceutical blister packs

Yahoo TechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FIRST AID: How to make pension funds pay for Biotech

euractiv.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Takeda Pharmaceutical Company Limited (TAK) stock price, news, quote and history

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stopped: The Six-Year Cost of Trials That Never Reached the Finish Line

BioPharma APACOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dimerix (ASX:DXB) Adds a Phase 2 Asset and Secures a New US Patent—Has Its Biotech Pipeline Just Been Transformed?

KalkineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca’s Q2 Net Profit Hits $2.5B Amid Fallout From Wainua Clinical Trial Failure

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea selects manager for ₩170 bil. phase 3 fund, moves closer to ₩1 tri. bio megafund

koreabiomed.comOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Complex Simulations: New Findings on Proton Transport in Water

Heidelberg UniversityOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National Norovirus and Rotavirus Report, week 31 report: data to week 30 (26 July 2026)

Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England du...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Small Cap Wrap: Quarterlies, acquisitions and biotech breakthroughs

Proactive financial newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UCL Kenya Secures Landmark Merck HIV Prevention Pill Deal

streamlinefeed.co.keOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 31 report: data to week 30 (data up to 26 July 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Denmark’s foundation‑fueled biotech boom redraws the Nordic map

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Digital and Intelligent Health Forum|Wang Zunlong: Building new benchmark for medical data, AI integration in Xi'an

China DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese biotech overtakes AI as emerging-market growth trade

The Edge MalaysiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

argenx to Acquire Forte Biosciences for $2.2 Billion, Gains FB102 Antibody

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Oral Revolution in Inflammatory Skin Disease: What Povorcitinib’s Phase 3 Design Reveals About the Next Wave of Dermatology Trials

The Clinical Trial VanguardOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese biotech overtakes AI as emerging-market growth trade

The Edge SingaporeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech Inc (PMCB) Earnings Forecast: Future EPS & Revenue Growth Estimates

TradingKeyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[4519.T FY2026 Q2 Earnings Call] Chugai Pharmaceutical Q2 Core Operating Profit Rises 21% to ¥329.1 Billion as Overseas Blockbusters and New Drug Royalties Diversify Revenue Structure

finance.biggo.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Update on Phase III trial of Ultomiris in adults and adolescents with thrombotic microangiopathy after haematopoietic stem cell transplant

AstraZenecaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Korea Investment Partners Chosen to Manage 'Phase 3 Trial Fund' Targeting 150 Billion Won

Seoul Economic DailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers

AstraZenecaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Chinese Biotech Overtakes AI as Emerging-Market Growth Trade

Bloomberg.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kolon TissueGene officially apologized to shareholders for failing to achieve its goal in the first

매일경제Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Compounded GLP-1 drugs creating concern among doctors and FDA

FOX40Original source
🌍discoverynews.google.comTier 3 · Aggregated media

CHA Biotech wins $1.7 mil. government AI project for cell therapy documentation

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ETF Showdown: XBI vs PBE, Which Biotech Fund Wins?

AOL.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Otsuka Receives FDA Approval for First-in-Class SIMTRIYO® (centanafadine) for the Treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in Adults and Pediatric Patients Aged 6 Years and Older

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

K-Bio 1 Trillion Mega Fund 'Imminent', 'First-Ever' Phase 3 Clinical Trial Fund Launch! : 경제 : JKN

재경일보Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Washington House passes FDA bill to move medicine testing beyond animals

The Cool DownOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zhejiang Huakang Pharmaceutical Co., Ltd. Class A Revenue Breakdown – SSE:605077

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Response highlights Puneites’ growing participation in holding eateries accountable: FDA Joint Commissioner

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Summit, Merck must navigate new regulatory terrain in China-first cancer landscape

BioSpaceOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA warns Texas seafood importer about repeat HACCP verification failures

foodsafetynews.comOriginal source